| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/04/1993 | EP0554032A2 Bicyclic suflur-containing compounds for the treatment of diseases coursed by immune system disorders compounds |
| 08/04/1993 | EP0553786A2 Salts of glucopyranose derivative and its intermediate |
| 08/04/1993 | EP0553291A1 Treatment of autoimmune diseases by oral administration of autoantigens |
| 08/04/1993 | EP0553244A1 Targeted immunostimulation with bispecific reagents |
| 08/04/1993 | EP0553198A1 Regulation of immunoglobulin production by interleukin-9 |
| 08/04/1993 | EP0536119A4 Immunoregulatory agents |
| 08/04/1993 | EP0355095B1 Pharmacological agent-lipid solution preparation |
| 08/04/1993 | EP0351435B1 Fused pyridazine compounds and their medicinal uses |
| 08/04/1993 | CN1074937A 4,5-dihydro geldanamycin, preparation of its hydroquinone, and applications |
| 08/04/1993 | CN1021733C Process for preparation of indolylpiperidine compounds |
| 08/03/1993 | US5232930 2-heteroaryl-substituted benzodioxoic having 5-lipoxygenase inhibitory activity |
| 08/03/1993 | US5232929 Treatment and prevention of inflammatory and central nervous system disorders |
| 08/03/1993 | US5232690 Use of zinc calcium hydroxide, lecithin and pao as an adjuvant for antigen solutions, and antigen solutions treated with an adjuvant of this type |
| 08/03/1993 | CA1320907C Cell membrane proteins, compositions containing them and procedure for their preparation |
| 08/03/1993 | CA1320906C Interleukin-2 induced antineoplastic peptide |
| 07/28/1993 | EP0552516A1 Aqueous synthetic organ-extracts |
| 07/28/1993 | EP0552309A1 New process for biophosphorylating organic compounds |
| 07/28/1993 | EP0552256A1 Method of treating or preventing type 1 diabetes by oral administration of insulin |
| 07/28/1993 | EP0552254A1 Crystallization of optical isomers of leukotriene antagonists |
| 07/28/1993 | EP0552245A1 Bis-benzo cyclohepta piperidylidene, piperidine and piperazine compounds, compositions and methods of use |
| 07/28/1993 | EP0552142A1 T cell receptor peptides as therapeutics for autoimmune and malignant disease |
| 07/28/1993 | EP0458965A4 Process for the preparation of vinyl ethers |
| 07/28/1993 | CN1074681A Benzopyran and related LTB4 Antagonists |
| 07/28/1993 | CA2107097A1 Icam-related protein |
| 07/27/1993 | US5231103 Quinolin-2-yl-methoxybenzylhydroxyureas |
| 07/27/1993 | US5231101 Antihistamines |
| 07/27/1993 | US5230887 Autoimmune disease |
| 07/23/1993 | CA2087823A1 Medical use for atypical beta-adrenoceptor agonists |
| 07/22/1993 | WO1993014215A1 Process and uses for 4,5-dihydrogeldanamycin and its hydroquinone |
| 07/22/1993 | WO1993014207A1 Chimeric immunogens |
| 07/22/1993 | WO1993014116A1 Hepatitis e virus peptide antigens and antibodies |
| 07/22/1993 | WO1993014113A1 Peptides with tachykinin antagonist activity |
| 07/22/1993 | WO1993014082A1 Pyridyl substituted imidazoles |
| 07/22/1993 | WO1993014081A1 Imidazole derivatives and their use as cytokine inhibitors |
| 07/22/1993 | WO1993014072A1 Amino acid derivatives as paf-receptor antagonists |
| 07/22/1993 | WO1993014070A2 Novel imidazole derivatives, their preparation and therapeutic applications |
| 07/22/1993 | WO1993013785A1 Induced tolerance to xenografts |
| 07/22/1993 | WO1993013782A1 Use of ruthenium red for inhibiting immune response |
| 07/22/1993 | WO1993013774A1 Methods for preventing mycobacterial infections with rifabutin |
| 07/22/1993 | WO1993013772A1 Methods for using histamine derivatives as immunomodulators and in immunotherapeutics |
| 07/22/1993 | WO1993010742A3 Chemical compounds, their preparation and use |
| 07/22/1993 | WO1993006852A3 Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein |
| 07/22/1993 | WO1993002693A3 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity |
| 07/22/1993 | CA2368862A1 Imidazole derivatives and their use as cytokine inhibitors |
| 07/22/1993 | CA2351694A1 Imidazole derivatives and their use as cytokine inhibitors |
| 07/22/1993 | CA2314425A1 Imidazole derivatives and their use as cytokine inhibitors |
| 07/22/1993 | CA2128331A1 Methods for using histamine derivatives as immunomodulators and in immunotherapeutics |
| 07/22/1993 | CA2127457A1 Process and uses for 4,5-dihydrogeldanamycin and its hydroquinone |
| 07/22/1993 | CA2127365A1 Amino acid derivatives as paf-receptor antagonists |
| 07/22/1993 | CA2126094A1 Induced tolerence to xenografts |
| 07/22/1993 | CA2125700A1 Hepatitis e virus peptide antigens and antibodies |
| 07/22/1993 | CA2117385A1 Use of ruthenium red for inhibiting immune response |
| 07/21/1993 | EP0552106A1 Peptide antagonists of bradykinin |
| 07/21/1993 | EP0552031A1 Oxepane isomers of rapamycin useful as immunosuppressive agents |
| 07/21/1993 | EP0552018A1 Use of Rifabutin for delaying or preventing mycobacterial infections |
| 07/21/1993 | EP0551440A1 Design of bioactive peptides based on immunoglobulin structure |
| 07/21/1993 | EP0551301A1 Cd53 cell surface antigen and use thereof |
| 07/20/1993 | US5229378 Antioxidant, antiinflammatory, antiallergen |
| 07/20/1993 | US5229367 Prostaglandin inhibitor, phospholipase inhibitor |
| 07/20/1993 | US5229115 Adoptive immunotherapy with interleukin-7 |
| 07/20/1993 | US5229109 Cancer treatment; side effect reduction |
| 07/20/1993 | CA1320498C2 Methods and compositions for inhibiting lipoxygenase |
| 07/20/1993 | CA1320490C Anti-inflammatory agents |
| 07/18/1993 | CA2087379A1 Pseudopeptidic derivatives having an antigonistic activity for bradykinine, process for their preparation and pharmaceutical compositions containing them |
| 07/14/1993 | EP0550807A2 Use of preparations of Curcuma plants |
| 07/14/1993 | EP0550668A1 Ibuprofen-antihistamine combinations |
| 07/14/1993 | EP0550663A1 Modified antibodies with controlled clearance time |
| 07/14/1993 | EP0550574A1 Heterocyclic compounds |
| 07/14/1993 | EP0550570A1 Xanthine derivatives |
| 07/14/1993 | EP0550559A1 Xanthines |
| 07/14/1993 | EP0550482A1 Methods for inhibiting rejection of transplanted tissue |
| 07/14/1993 | CN1074135A Adjuvants |
| 07/13/1993 | CA1320203C2 Intermediates for 9-deazaguanines |
| 07/13/1993 | CA1320201C 4,5,6-substituted-2-pyrimidinamines |
| 07/13/1993 | CA1320196C Immunostimulating guanine derivatives, compositions and methods |
| 07/13/1993 | CA1320194C Substituted pyrroles |
| 07/13/1993 | CA1320129C Synergistic behavior of csf-1 and g-csf |
| 07/08/1993 | WO1993013210A1 Icams immunoglobulin constant region soluble fusion proteins |
| 07/08/1993 | WO1993013117A2 5- or 6-aminodeoxyfuranoside derivatives with antiinflammatory and antiproliferative activity |
| 07/08/1993 | WO1993013089A1 Macrocyclic polyether carboxylic acids |
| 07/08/1993 | WO1993013075A1 1-(arylalkyl-aminoalkyl)imidazole derivatives, processes of preparation and use as therapeutical agents |
| 07/08/1993 | WO1993013055A1 Amidino derivatives and their use as nitric oxide synthase inhibitors |
| 07/08/1993 | WO1993013052A1 α-SUBSTITUTED BENZENEMETHANAMINE DERIVATIVES |
| 07/08/1993 | WO1993012814A2 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 07/08/1993 | WO1993012810A1 Pharmaceutical pentapeptide compositions and methods of use thereof |
| 07/08/1993 | WO1993012789A1 Use of spiperone or spiperone derivatives as immunosuppressant agents |
| 07/08/1993 | WO1993012654A1 Medical uses of trioxolane and diperoxide compounds |
| 07/08/1993 | CA2127275A1 Pharmaceutical pentapeptide compositions and methods of use thereof |
| 07/08/1993 | CA2126757A1 Medical uses of trioxolane and diperoxide compounds |
| 07/08/1993 | CA2126686A1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 07/08/1993 | CA2126678A1 Use of spiperone or spiperone derivatives as immunosuppressant agents |
| 07/08/1993 | CA2126177A1 Therapeutic agents |
| 07/08/1993 | CA2125676A1 .alpha.-substituted benzenemethanamine derivatives |
| 07/08/1993 | CA2104477A1 Anti-proliferative and anti-inflammatory compounds: 5- 6-deoxy hexose monosaccharides having a saturated nitrogen-containing heterocycle at the 5- 6-position bound through the nitrogen atom |
| 07/07/1993 | EP0550020A2 Anti-human IgE monoclonal antibodies |
| 07/07/1993 | EP0550008A2 Use of N-acyl derivatives of aminoalcohols with polycarboxylic acids for the manufacture of a medicament for the treatment of pathologies relating to mast cells |
| 07/07/1993 | EP0550006A2 Use of N-acyl derivatives of aminoalcohols for the manufacture of a medicament for the treatment of pathologies involving mast cells |
| 07/07/1993 | EP0549880A1 N-(3-(2-(1H-imidazol-1-yl)ethoxy)phenyl)-4-(2-thienyl)-2-pyrimidinamine and pharmacologically acceptable salts |
| 07/07/1993 | EP0549797A1 Isoxazole compound, pharmaceutically acceptable salt thereof, and medicinal use thereof |
| 07/07/1993 | EP0549711A1 Natural killer stimulatory factor |